Date published: 2025-12-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

RACK7 Inhibitors

RACK7 inhibitors represent a class of chemical compounds designed to target and modulate the activity of RACK7, also known as Receptor for Activated C Kinase 7. RACK7 is a protein that belongs to a family of scaffold proteins known as receptor for activated protein kinase C (RACK) proteins. These scaffold proteins play a pivotal role in intracellular signal transduction by facilitating the interaction between signaling molecules, kinases, and their substrates. RACK7, in particular, has been identified as an important player in regulating cellular processes such as cell growth, differentiation, and migration, as well as participating in various signaling pathways. Inhibitors of RACK7 are designed to interfere with its interactions with other cellular components or to modulate its activity, ultimately affecting the downstream signaling events it regulates.

The mechanisms by which RACK7 inhibitors function can vary, depending on their chemical structures and binding properties. Some inhibitors may target specific domains or binding sites on the RACK7 protein, preventing its interactions with key signaling molecules. Others may disrupt the overall structure or stability of RACK7, leading to a loss of its scaffold function. By inhibiting RACK7, these compounds have the potential to influence the dynamics of cellular signal transduction pathways and modulate the outcomes of various biological processes. Ongoing research in this field aims to elucidate the precise mechanisms and downstream effects of RACK7 inhibition, furthering our understanding of its role in cellular biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

JQ1 is a small molecule inhibiting BET bromodomains, impacting chromatin remodeling and potentially influencing RACK7-mediated transcription regulation.

GSK 525762A

1260907-17-2sc-490339
sc-490339A
sc-490339B
sc-490339C
sc-490339D
5 mg
10 mg
50 mg
100 mg
1 g
$300.00
$540.00
$940.00
$1680.00
$5900.00
(0)

I-BET762 is a BET bromodomain inhibitor, altering chromatin dynamics and potentially affecting RACK7's chromatin-associated roles.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Vorinostat is an HDAC inhibitor, modifying chromatin structure and possibly impacting RACK7's interaction with chromatin.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A, another HDAC inhibitor, can change chromatin conformation, potentially influencing RACK7 activity.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor changes DNA methylation patterns, potentially affecting RACK7's gene regulatory functions.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Similar to 5-Azacytidine, Decitabine is a DNA methyltransferase inhibitor, potentially impacting RACK7's regulatory roles.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

MS-275 is an HDAC inhibitor, which could alter chromatin states and indirectly influence RACK7 activities.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG108, a DNA methyltransferase inhibitor, may indirectly affect RACK7 by altering gene expression patterns.

SGC-CBP30

1613695-14-9sc-473871
sc-473871A
5 mg
10 mg
$178.00
$338.00
(0)

SGC-CBP30 targets CBP/p300 bromodomains, potentially affecting transcription regulation pathways involving RACK7.

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$90.00
$238.00
$300.00
(0)

GSK126, an EZH2 methyltransferase inhibitor, might influence chromatin states affecting RACK7's function.